Zenith Drugs IPO — Listing Performance
Zenith Drugs IPO facts & figures
| Issue category | SME |
|---|---|
| Issue open date | 19 Feb 2024 |
| Listing date | 27 Feb 2024 |
| Issue price | ₹79 |
| Listing-day close | ₹105.15 (33.1%) |
| Recent market price | ₹47.85 (-39.43% vs issue) |
| 52-week range | ₹35.20 – ₹70.95 |
| Identifiers | NSE: ZENITHDRUG · ISIN: INE0QWN01013 |
How the listing went
Zenith Drugs had a strong market debut, ending listing day 33.1% over the issue price.
Zenith Drugs against every other debut on record
- Rank in 2024: 128 of 262 NSE debuts, on a 33.1% first-day close.
- 45th percentile of 176 SME debuts in 2024 (median 41.27%).
- 12th of 25 debuts in February 2024.
- Opened 39.24% above issue, then gave up 6.14 points to the close.
- Day-one range ₹104.50 to ₹114.50: a 12.66% swing on the issue price.
- Last close ₹47.85 (11 Sep 2026): 39.43% below issue, against 33.1% on day one.
- 35% up its 52-week range of ₹35.20 to ₹70.95.
- Priced at the top of the ₹75 to ₹79 band.
- Listed 5 calendar days after close.
- All 601 SME debuts on record: median 14.22%, 79% closed above issue.
Computed over 1109 verified NSE debuts to 11 Sep 2026 · sources